Articles related to BONE HEALTH

23 million Americans take levothyroxine daily, making it one of the nation’s most prescribed medications, with new evidence suggesting potential risks to bone health even at standard therapeutic levels.

Magnesium glycinate supplementation may offer benefits for various health conditions, including anxiety, bone health, blood sugar management, and premenstrual syndrome symptoms.

Convincing bone loss would be bone loss at more than 1 site or over more than 1 interval, or bone loss associated with elevated markers of bone turnover such as cross-linked C-telopeptide of type-1 collagen (CTx) greater than 300 pg/mL.

Chronic daily ingestion of preformed vitamin A above the recommended intake but below the tolerable upper intake may still be harmful, especially to the musculoskeletal system.

Extraosseous calcification in chronic and end-stage kidney disease involves a complex pathogenesis, impacting patient morbidity and mortality through vascular, soft tissue, and calciphylaxis manifestations.

IL-1B significantly influences breast cancer bone metastasis by promoting EMT, enhancing osteoclast activity, and creating a conducive metastatic niche. Targeting IL-1B in combination with standard therapies shows promising potential to reduce metastatic outgrowth.